Understanding GAREM1: A Potential Drug Target (G64762)

Target Name: GAREM1

NCBI ID: G64762

GAREM1

Understanding GAREM1: A Potential Drug Target

GAREM1 (GRB2 associated regulator of MAPK1) is a protein that plays a crucial role in cell signaling pathways. It is a key regulator of the MAPK1 signaling pathway, which is involved in a wide range of cellular processes, including cell growth, differentiation, and response to stimuli. GAREM1 is a protein that is often targeted by drug developers because of its potential as a drug or biomarker. In this article, we will explore the biology of GAREM1 and its potential as a drug target.

GAREM1 is a protein that is expressed in a wide range of tissues and cells. It is primarily localized to the cytoplasm of cells and is also found in the nucleus. GAREM1 is a 21-kDa protein that has four known isoforms. It is highly conserved, with a calculated pI of 5.5. GAREM1 is a protein that is known to be involved in the MAPK1 signaling pathway.

The MAPK1 signaling pathway is a critical pathway that is involved in a wide range of cellular processes. It is a ser/thr protein that is involved in the regulation of cell growth, differentiation, and response to stimuli. The MAPK1 signaling pathway is activated by the addition of small molecules, including inhibitors and activators. These small molecules cause changes in the levels of various proteins, including GAREM1.

GAREM1 is a key regulator of the MAPK1 signaling pathway. It is a protein that is involved in the regulation of the MAPK1 kinase, which is the enzyme that activates the MAPK1 signaling pathway. GAREM1 is a protein that is highly conserved and has a calculated pI of 5.5. This means that it is resistant to many small molecules, including inhibitors.

GAREM1 is also involved in the regulation of the MAPK1-associated protein (MAPK1) kinase. This protein is a critical regulator of the MAPK1 signaling pathway and is involved in the regulation of cellular processes such as cell growth, differentiation, and response to stimuli. GAREM1 is a protein that is known to be involved in the regulation of MAPK1-associated protein (MAPK1) kinase.

In conclusion, GAREM1 is a protein that is involved in the regulation of the MAPK1 signaling pathway. It is a key regulator of the MAPK1 kinase and is also involved in the regulation of MAPK1-associated protein (MAPK1) kinase. As a result, GAREM1 is a protein that has great potential as a drug target or biomarker. Further research is needed to fully understand the biology of GAREM1 and its potential as a drug.

Protein Name: GRB2 Associated Regulator Of MAPK1 Subtype 1

Functions: Acts as an adapter protein that plays a role in intracellular signaling cascades triggered either by the cell surface activated epidermal growth factor receptor and/or cytoplasmic protein tyrosine kinases. Promotes activation of the MAPK/ERK signaling pathway. Plays a role in the regulation of cell proliferation

The "GAREM1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GAREM1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets